Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-23-003166

EVP and CFO sold 105,610 shares at an average $46.65 ($4,926,251)

  • EVP and CFO acquired 45,610 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Brennan Daniel J. · EVP and CFO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Exercise or conversion : show line 1 in the form +16,863 $17.26 $291,055 302,821 D
2023-03-01 Exercise or conversion : show line 2 in the form +15,086 $16.31 $246,053 317,907 D
2023-03-01 Exercise or conversion : show line 3 in the form +13,661 $13.08 $178,686 331,568 D
2023-03-01 Sale : show line 4 in the form −75,610 $46.64 $3,526,337 255,958 D
2023-03-02 Sale : show line 5 in the form −30,000 $46.66 $1,399,914 225,958 D
Open-market sales · 105,610 sh · avg $46.65 · $4,926,251

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2023-03-01 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −16,863 33,728 D
2023-03-01 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −15,086 30,173 D
2023-03-01 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −13,661 13,662 D
Loading xslF345X03/doc4.xml…